English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Objective  T-cells are critical players in the pathogenesis of osteoporosis in patients with rheumatoid arthritis (RA). Premature senescence of lymphocytes including the accumulation of senescent CD4 +  T-cells is a hallmark feature of RA. Whether T-cell senescence is associated with bone loss in RA patients is elusive so far.    Methods  This includes a prospective study of consecutive patients with RA ( n  = 107), patients with primary osteopenia/-porosis ( n  = 75), and healthy individuals ( n  = 38). Bone mineral density (BMD) was determined by dual-energy X-ray absorptiometry scan. Flow cytometry, magnetic-associated cell sorting, and cell culture experiments were performed to analyze the pro-osteoclastic phenotype and the function of senescent CD4 + CD28 −  T-cells.    Results  Patients with osteopenia/-porosis yielded a higher prevalence of senescent CD4 + CD28 −  T-cells than individuals with normal BMD, in the RA, as well as in the non-RA cohort. Receptor activator of nuclear factor kappa-B ligand (RANKL) was expressed at higher levels on CD4 + CD28 −  T-cells as compared to CD28 +  T-cells. Stimulation with interleukin-15 led to an up-regulation of RANKL expression, particularly on CD28 −  T-cells. CD4 + CD28 −  T-cells induced osteoclastogenesis more efficiently than CD28 +  T-cells.    Conclusion  Our data indicate that senescent T-cells promote osteoclastogenesis more efficiently than conventional CD28 +  T-cells, which might contribute to the pathogenesis of systemic bone loss in RA and primary osteoporosis.

Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis